US starts trial of COVID-19 vaccine in pregnant women
One thousand women will take part, according to the National Institutes of Health
The US National Institutes of Health (NIH) has announced the launch of a study to evaluate the immune responses generated by COVID-19 vaccines in pregnant or postpartum women.
Pregnant women are at higher risk of complications from COVID-19 including premature birth, high blood pressure with organ failure risk, need for intensive care and possible death, according to the NIH.
A small study conducted in February in Israel showed that antibodies were detected in all 20 women
